Table 1 PDAC patient demographics and clinical data
Measurement | Median (range) | Measurement | n (%) |
|---|---|---|---|
Age | 70 (36–90) | Surgery | |
BMI (kg/m2) | 23.7 (17.5–41.3) | Yes | 6 (15.4) |
Size (cm) | 6 (2–8) | No | 32 (82.0) |
Gender | n (%) | N/A | 1 (2.6) |
Male | 22 (56.4) | Metastatic disease | |
Female | 17 (43.6) | None | 3 (7.7) |
Race | N/A | 11 (28.2) | |
Asian | 4 (10.3) | Ascites | 1 (2.6) |
Black | 5 (12.8) | Bone | 1 (2.6) |
White | 25 (64.1) | Breast | 1 (2.6) |
Other | 4 (10.3) | Kidney | 1 (2.6) |
NA | 1 (2.6) | Liver | 12 (30.8) |
Ethnicity | LN | 3 (7.7) | |
Hispanic | 6 (15.4) | Lung | 5 (12.8) |
Non-Hispanic | 32 (82.1) | Peritoneal | 4 (10.3) |
N/A | 1 (2.6) | Suspicious for liver | 2 (5.1) |
KRAS mutation | Disease response | ||
KRAS G12C | 1 (2.6) | Stable | 5 (12.8) |
KRAS G12D | 7 (17.9) | Progressive | 25 (64.1) |
KRAS G12R | 3 (7.7) | Recurrent | 1 (2.6) |
KRAS G12V | 6 (15.4) | N/A | 8 (20.5) |
None | 21 (53.8) | ||
N/A | 1 (2.6) |
